DTCFF (Defence Therapeutics) Other Current Receivables: $0.00 Mil (As of Mar. 2026)


DTCFF Defence Therapeutics Inc DTCFF
30 GF Score
Price $0.30
! 1 Warning Sign
View Full Analysis

What is Defence Therapeutics Other Current Receivables?

Defence Therapeutics DTCFF -0.18% 30 Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus rates DTCFF with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Defence Therapeutics's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.00 Mil.

Defence Therapeutics Other Current Receivables Related Terms

Defence Therapeutics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Defence Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Defence Therapeutics Other Current Receivables Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial 0.06 0.00 0.00 0.00 0.00

Defence Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DTCFF
30GF Score
Defence Therapeutics Inc DTCFF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Defence Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Defence Therapeutics (DTCFF) has a Other Current Receivables of $0.00 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Defence Therapeutics and its competitors.
Is Defence Therapeutics' Other Current Receivables too high?
Defence Therapeutics' current Other Current Receivables is $0.00 Mil. Overall, Defence Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Defence Therapeutics' Other Current Receivables compare to VRTX and REGN?
Defence Therapeutics' Other Current Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Defence Therapeutics and its competitors. Defence Therapeutics's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Defence Therapeutics stock overvalued right now?
Defence Therapeutics (DTCFF) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Defence Therapeutics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Defence Therapeutics (DTCFF), the current Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Defence Therapeutics Business Description

Other Exchanges DTC:GermanyDTC:Canada
Address 7171 Frederick Banting Street, Montreal, QC, CAN, H4S 1Z9
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.
30GF Score

Get the complete analysis for DTCFF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price